Inventor · disambiguated record
Anita Hamilton
Also filed as: HAMILTON ANITA · HAMILTON ANITA A · HAMILTON ANITA ANNE
20 granted patents·12 pending applications·620 citations·filing 2000–2021
96Inventor score
Files withMERCK PATENT GMBH9AGEN BIOMEDICAL LTD4BIOVATION LTD3CORNELL RES FOUNDATION INC2HOFMEISTER ROBERT2
Top patents by PatentIndex Score
32 records- 0198US6992174B2Reducing the immunogenicity of fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2002·Granted Jan 31, 2006·94 cites·2 claims
- 0296US7514078B2Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodiesCORNELL RES FOUNDATION INC·Filed 2003·Granted Apr 7, 2009·75 cites·140 claims
- 0395US8076459B2Multispecfic deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2004·Granted Dec 13, 2011·97 cites·31 claims
- 0495US7045605B2Modified antibodies to prostate-specific membrane antigen and uses thereofCORNELL RES FOUNDATION INC·Filed 2002·Granted May 16, 2006·80 cites·142 claims
- 0594US9102736B2Multispecific deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2011·Granted Aug 11, 2015·37 cites·37 claims
- 0694US7125689B2Method for rendering streptokinase less immunogenic to a humanBIOVATION LTD·Filed 2002·Granted Oct 24, 2006·67 cites·1 claims
- 0792US7601814B2Reducing the immunogenicity of fusion proteinsMERCK PATENT GMBH·Filed 2005·Granted Oct 13, 2009·10 cites·7 claims
- 0891US7189830B2Anti-KSA/IL-2 fusion proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Mar 13, 2007·29 cites·1 claims
- 0991US7132511B2Modified anti-EGFR antibodies with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Nov 7, 2006·46 cites·3 claims
- 1089US7430476B2Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Sep 30, 2008·24 cites·5 claims
- 1187US7465572B2De-immunized streptokinaseMERCK PATENT GMBH·Filed 2006·Granted Dec 16, 2008·4 cites·2 claims
- 1286US7910104B2Modified anti-CD52 antibodyMERCK PATENT GMBH·Filed 2007·Granted Mar 22, 2011·6 cites·4 claims
- 1385US7973150B2Reducing the immunogenicity of fusion proteinsMERCK PATENT GMBH·Filed 2009·Granted Jul 5, 2011·3 cites·2 claims
- 1484US7264806B2Modified anti-CD52 antibodyBIOVATION LTD·Filed 2004·Granted Sep 4, 2007·15 cites·2 claims
- 1584US7087724B2Carrier moleculesAGEN BIOMEDICAL LTD·Filed 2002·Granted Aug 8, 2006·7 cites·8 claims
- 1681US8926973B2Reducing the immunogenicity of fusion proteinsGILLIES STEPHEN D·Filed 2011·Granted Jan 6, 2015·2 cites·4 claims
- 1781US7615217B2Artificial proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2007·Granted Nov 10, 2009·3 cites·6 claims
- 1881US6927025B1Methods for protein screeningBIOVATION LTD·Filed 2000·Granted Aug 9, 2005·21 cites·8 claims
- 1974US12142767B2Metal oxides in lead-acid batteriesTROJAN BATTERY COMPANY LLC·Filed 2021·Granted Nov 12, 2024·0 cites·11 claims
- 2064US2009092546A1Carrier moleculesAGEN BIOMEDICAL LTD·Filed 2008·Application pending·0 cites
- 2164US2020014030A1Metal oxides in lead-acid batteriesTROJAN BATTERY IRELAND LTD·Filed 2019·Application pending·0 cites
- 2261US2008248529A1Modified anti-cd52 antibodyCARR FRANCIS J·Filed 2007·Application pending·0 cites
- 2360US7459143B2Carrier moleculesAGEN BIOMEDICAL LTD·Filed 2006·Granted Dec 2, 2008·0 cites·3 claims
- 2460US2015141626A1Reducing the immunogenicity of fusion proteinsMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 2559US2005118169A1Antibodies against interleukin-1 receptor and uses thereofFiled 2004·Application pending·0 cites
- 2657US2018047990A1Metal oxides in lead-acid batteriesTROJAN BATTERY IRELAND LTD·Filed 2017·Application pending·0 cites
- 2757US2009191187A1Antibodies against interleukin-1 receptor and uses thereofBARTKE ILSE·Filed 2009·Application pending·0 cites
- 2855US2010286375A1Carrier moleculesAGEN BIOMEDICAL LTD·Filed 2010·Application pending·0 cites
- 2954US2005176028A1Deimmunized binding molecules to CD3Filed 2004·Application pending·0 cites
- 3053US2007292416A1De-Immunized Anti-Cd3 AntibodyALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 3140US2004072219A1Modified leptin with reduced immunogenicityFiled 2002·Application pending·0 cites
- 3236US2007224196A1Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereonELUSYS THERAPEUTICS INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anita Hamilton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →